Stonepine Capital Management, LLC Kezar Life Sciences, Inc. Transaction History
Stonepine Capital Management, LLC
- $124 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding KZR
# of Institutions
34Shares Held
26.7MCall Options Held
13.8KPut Options Held
600-
Suvretta Capital Management, LLC New York, NY7.17MShares$42.1 Million0.22% of portfolio
-
Avidity Partners Management LP Dallas, TX5.03MShares$29.5 Million0.24% of portfolio
-
Tang Capital Management LLC San Diego, CA3.64MShares$21.4 Million0.24% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.93MShares$11.3 Million0.03% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny1.4MShares$8.24 Million0.0% of portfolio
About Kezar Life Sciences, Inc.
- Ticker KZR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,369,504
- Market Cap $401M
- Description
- Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...